Agency Information Collection Activities; Announcement of OMB Approval; Adverse Experience Reporting for Licensed Biological Products; and General Records
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Adverse Experience Reporting for Licensed Biological Products; and General Records” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Table of Contents Back to Top
FOR FURTHER INFORMATION CONTACT: Back to Top
JonnaLynn Capezzuto, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: Back to Top
In the Federal Register of January 23, 2003 (68 FR 3262), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0308. The approval expires on May 31, 2005. A copy of the supporting statement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets.
Dated: May 16, 2003.
Assistant Commissioner for Policy.
[FR Doc. 03-12920 Filed 5-22-03; 8:45 am]
BILLING CODE 4160-01-S